No CrossRef data available.
Article contents
The stereological investigation of conditioned medium originated from human adipose tissue-derived mesenchymal stem cells and platelet-rich plasma effects on polycystic ovary syndrome in a rat model
Published online by Cambridge University Press: 24 September 2025
Abstract
Background:
Platelet-rich plasma (PRP) and conditioned medium (CM) originating from human adipose tissue mesenchymal stem cells (ATMSCs) as two enriched sources of growth factors have a potential impact on tissue repair.
Objective:
This investigation aimed to investigate the effects of PRP and CM on ovarian structures in letrozole-induced polycystic ovarian syndrome (PCOS) in female rats through the stereological methods.
Materials and Methods:
To obtain PRP, blood samples from Wistar rats were collected in citrate tubes, centrifuged (400g, 10 min) to separate components. Plasma+Buffy coat was recentrifuged (800g, 10 min); Platelet-poor-plasma (PPP) discarded, PRP (lower layer) obtained and stored at − 20°C. To attain the mentioned mesenchymal CM, first, adipose tissue was collected from liposuction samples by collagenase digestion and cultured in DMEM/FBS. To approve the isolation of ATMSCs, the flow cytometry method, based on the expression status of CD44, CD90, CD34 and CD45 markers, was carried out. ATMSCs were then grown in serum-free DMEM, and supernatant was centrifuged and stored. Forty female Wistar rats were allocated into five groups (Control, negative control (letrozole [LTZ]), letrozole and PRP [LTZ-PRP], letrozole and CM [LTZ-CM] and letrozole and PRP + CM [LTZ-PRP + CM] groups). The Control group received normal saline (0.9% NaCl, 200 μl) orally. In the negative control, PCOS was induced by letrozole (1 mg/kg dissolved in normal saline, daily). Animals were treated by PRP, CM and PRP + CM (200 μL, IP, 1 and 14 days after PCOS induction). At the end of the experiment, body mass index (BMI) and body weight were evaluated, and then, blood samples were taken for the evaluation of serum testosterone level. The animals were dissected, and their ovaries were excised, fixed, sectioned and stained by H&E. Stereological approaches were utilized for estimation of the volume of the ovary, ovarian cortex and medulla, corpus luteum, oocytes, ovarian cysts and the number of different ovarian follicles and granulosa cells.
Results:
In the LTZ-PRP and LTZ-CM groups, ovarian weight (OW) was significantly increased compared to the LTZ group (P < 0.001 and P < 0.05, respectively). The cortex volume (CV) and ovarian volume (OV) of the LTZ-PRP group were dramatically elevated compared to the LTZ group (P < 0.0001). A remarkable elevation of the preantral follicles number (PFN) in the mentioned group compared to the LTZ group was also observed (P < 0.05). The estimation of the antral follicle number (AFN), atretic follicle number (AtFN) and granulosa cell number (GCN) in the LTZ-PRP group showed a significant increment compared to the LTZ group (P < 0.0001). The PFN and AFN in the LTZ-CM group compared to the LTZ group were significantly elevated (P < 0.01). In this group, AtFN and GCN were also increased significantly in comparison with the LTZ group (P < 0.001). In terms of serum testosterone level (STL), there was a significant elevation in the LTZ-PRP group compared to the LTZ group (P < 0.0001). Regarding the LTZ-PRP + CM group, the body weight (BW) and body mass index (BMI) were considerably higher than the LTZ-CM group (P < 0.05 and P < 0.01, respectively). CV and OV were also increased significantly compared to the LTZ-CM group (P < 0.001). The AtFN in this group was considerably elevated in comparison with the LTZ-CM group (P < 0.0001). Moreover, STL in the mentioned combinatorial group was conspicuously increased compared to the LTZ-CM group (P < 0.0001).
Conclusion:
PRP, alone and combined with CM, promoted parameters related to the weight and volume of the cortex and the ovary, and the number of granulosa cells and follicles in different phases compared with the PCOS group. Thus, it seems that the PRP has a more prominent role regarding these parameters than CM. However, more research is recommended to validate these results.
Keywords
Information
- Type
- Research Article
- Information
- Copyright
- © The Author(s), 2025. Published by Cambridge University Press
References
Aboutalebi, H., Alipour, F., and Ebrahimzadeh-Bideskan, A. (2022) The protective effect of co-administration of platelet-rich plasma (PRP) and pentoxifylline (PTX) on cyclophosphamide-induced premature ovarian failure in mature and immature rats. Toxicology Mechanisms and Methods 32, 588–596.10.1080/15376516.2022.2057264CrossRefGoogle ScholarPubMed
Abdulghani, M. A., Alshehade, S. A., Kamran, S. and Alshawsh, M. A. (2022) Effect of monosodium glutamate on serum sex hormones and uterine histology in female rats along with its molecular docking and in-silico toxicity. Heliyon 8, 1–12.10.1016/j.heliyon.2022.e10967CrossRefGoogle ScholarPubMed
Ainehchi, N., Khaki, A., Ouladsahebmadarek, E., Hammadeh, M., Farzadi, L., Farshbaf-Khalili, A. and Shokoohi, M. (2020) The effect of clomiphene citrate, herbal mixture, and herbal mixture along with clomiphene citrate on clinical and para-clinical parameters in infertile women with polycystic ovary syndrome: a randomized controlled clinical trial. Archives of Medical Science 16, 1–18.10.5114/aoms.2020.93271CrossRefGoogle ScholarPubMed
Akbari, H., Eftekhar Vaghefi, S. H., Shahedi, A., Habibzadeh, V., Mirshekari, T. R., Ganjizadegan, A. and Nematollahi-Mahani, S. N. (2017) Mesenchymal stem cell-conditioned medium modulates apoptotic and stress-related gene expression, ameliorates maturation and allows for the development of immature human oocytes after artificial activation. Genes 8, 371–383.10.3390/genes8120371CrossRefGoogle ScholarPubMed
Anvari, S. S., Dehgan, G. and Razi, M. (2019) Preliminary findings of platelet-rich plasma-induced ameliorative effect on polycystic ovarian syndrome. Cell Journal (Yakhteh) 21, 243.Google Scholar
ArefNezhad, R., Rezaei-Tazangi, F., Roghani-Shahraki, H., Goleij, P., Zare, N., Motedayyen, H. and Aghazadeh, E. (2023) Human umbilical cord mesenchymal stem cells: Heralding an effective treatment against esophageal cancer?. Cell Biology International 47, 714–719.10.1002/cbin.11991CrossRefGoogle ScholarPubMed
Asadi-Golshan, R., Razban, V., Mirzaei, E., Rahmanian, A., Khajeh, S., Mostafavi-Pour, Z. and Dehghani, F. (2021) Efficacy of dental pulp-derived stem cells conditioned medium loaded in collagen hydrogel in spinal cord injury in rats: Stereological evidence. Journal of Chemical Neuroanatomy 116, 101–126.10.1016/j.jchemneu.2021.101978CrossRefGoogle ScholarPubMed
Atkinson, L., Martin, F. and Sturmey, R. G. (2021) Intraovarian injection of platelet-rich plasma in assisted reproduction: too much too soon?. Human Reproduction 36, 1737–1750.CrossRefGoogle ScholarPubMed
Bahmanpour, S., Khozani, T. T. and Tazangi, F. R. (2019) Evaluation of the Capability of the Wharton’s Jelly Mesenchymal Stem Cell Aggregates to Express the Markers of Three Germ Cell Lineages. Archives of Iranian Medicine (AIM) 22, 1–14.Google ScholarPubMed
Baptiste, C. G., Battista, M. C., Trottier, A. and Baillargeon, J. P. (2010) Insulin and hyperandrogenism in women with polycystic ovary syndrome. The Journal of steroid biochemistry and molecular biology 122, 42–52.10.1016/j.jsbmb.2009.12.010CrossRefGoogle ScholarPubMed
Behnoush, A. H., Maleki, S., Arzhangzadeh, A., Khalaji, A., Pezeshki, P. S., Vaziri, Z. and Hernandez, A. V. (2024) Prediabetes and major adverse cardiac events after acute coronary syndrome: an overestimated concept. Clinical Cardiology 47, e24–e36.10.1002/clc.24262CrossRefGoogle ScholarPubMed
Villa, J. and Pratley, R. E. (2011) Adipose tissue dysfunction in polycystic ovary syndrome. Current diabetes reports 11, 179–184.10.1007/s11892-011-0189-8CrossRefGoogle ScholarPubMed
Charleston, J. S., Hansen, K. R., Thyer, A. C., Charleston, L. B., Gougeon, A., Siebert, J. R. and Klein, N. A. (2007) Estimating human ovarian non-growing follicle number: the application of modern stereology techniques to an old problem. Human Reproduction 22, 2103–2110.10.1093/humrep/dem137CrossRefGoogle Scholar
Comish, P. B., Drumond, A. L., Kinnell, H. L., Anderson, R. A., Matin, A., Meistrich, M. L. and Shetty, G. (2014) Fetal cyclophosphamide exposure induces testicular cancer and reduced spermatogenesis and ovarian follicle numbers in mice. PLoS One 9, e93–e110.Google ScholarPubMed
Darlan, D. M., Trisnasi, S., Putra, A., Amalina, N. D. and Husain, S. A. (2024) Hypoxia Mesenchymal Stem Cell Secretome Enhances IL-10 via STAT3 Pathway in a Rat PCOS Model.Google Scholar
Dehghani, F., Aboutalebi, H., Esmaeilpour, T., Panjehshahin, M. R. and Bordbar, H. (2018) Effect of platelet-rich plasma (PRP) on ovarian structures in cyclophosphamide-induced ovarian failure in female rats: a stereological study. Toxicology mechanisms and methods 28, 653–659.10.1080/15376516.2018.1491662CrossRefGoogle ScholarPubMed
De Leo, V., Musacchio, M. C., Cappelli, V., Massaro, M. G., Morgante, G. and Petraglia, F. J. R. B. (2016) Genetic, hormonal and metabolic aspects of PCOS: an update. Reproductive Biology and Endocrinology 14, 1–17.10.1186/s12958-016-0173-xCrossRefGoogle ScholarPubMed
De Ronde, W. and de Jong, F. H. (2011) Aromatase inhibitors in men: effects and therapeutic options. Reproductive Biology and Endocrinology 9, 93–114.10.1186/1477-7827-9-93CrossRefGoogle ScholarPubMed
Ding, C., Zou, Q., Wu, Y., Lu, J., Qian, C., Li, H. and Huang, B. (2020) EGF released from human placental mesenchymal stem cells improves premature ovarian insufficiency via NRF2/HO-1 activation. Aging (Albany NY) 12, 299–314.Google ScholarPubMed
Dong, J., Albertini, D. F., Nishimori, K., Kumar, T. R., Lu, N. and Matzuk, M. M. (1996) Growth differentiation factor-9 is required during early ovarian folliculogenesis. Nature 383, 531–535.10.1038/383531a0CrossRefGoogle ScholarPubMed
Druckmann, R. and Rohr, U. D. (2002) IGF-1 in gynaecology and obstetrics: update 2002. Maturitas 41, 65–83.10.1016/S0378-5122(02)00016-6CrossRefGoogle ScholarPubMed
Dubois, S. G., Floyd, E. Z., Zvonic, S., Kilroy, G., Wu, X., Carling, S. and Gimble, J. M. (2008) Isolation of human adipose-derived stem cells from biopsies and liposuction specimens. In Mesenchymal Stem Cells: Methods and Protocols (pp. 69–79). Totowa, NJ: Humana Press.10.1007/978-1-60327-169-1_5CrossRefGoogle Scholar
Emori, C. and Sugiura, K. (2014) Role of oocyte-derived paracrine factors in follicular development. Animal Science Journal 85, 627–633.10.1111/asj.12200CrossRefGoogle ScholarPubMed
Farimani, M., Heshmati, S., Poorolajal, J. and Bahmanzadeh, M. (2019) A report on three live births in women with poor ovarian response following intra-ovarian injection of platelet-rich plasma (PRP). Molecular biology reports 46, 1611–1616.10.1007/s11033-019-04609-wCrossRefGoogle ScholarPubMed
Fox, C. W., Zhang, L., Moeller, B. C., Garzo, V. G., Chang, R. J. and Duleba, A. J. (2021) Ibuprofen inhibits key genes involved in androgen production in theca–interstitial cells. F&S Science 2, 230–236.Google ScholarPubMed
Geva, E. and Jaffe, R. B. (2000) Role of vascular endothelial growth factor in ovarian physiology and pathology. Fertility and sterility 74, 429–438.10.1016/S0015-0282(00)00670-1CrossRefGoogle ScholarPubMed
Ghaneialvar, H., Soltani, L., Rahmani, H. R., Lotfi, A. S. and Soleimani, M. (2018) Characterization and classification of mesenchymal stem cells in several species using surface markers for cell therapy purposes. Indian Journal of Clinical Biochemistry 33, 46–52.10.1007/s12291-017-0641-xCrossRefGoogle ScholarPubMed
Hafen, E. and Stocker, H. (2003) How are the sizes of cells, organs, and bodies controlled?. PLoS Biology 1, e86–e99.10.1371/journal.pbio.0000086CrossRefGoogle ScholarPubMed
Han, Y., Li, X., Zhang, Y., Han, Y., Chang, F. and Ding, J. (2019) Mesenchymal stem cells for regenerative medicine. Cells 8, 886–895.10.3390/cells8080886CrossRefGoogle ScholarPubMed
He, Y., Chen, D., Yang, L., Hou, Q., Ma, H. and Xu, X. (2018) The therapeutic potential of bone marrow mesenchymal stem cells in premature ovarian failure. Stem cell research & therapy 9, 263–274.10.1186/s13287-018-1008-9CrossRefGoogle ScholarPubMed
Hesari, R., Keshvarinia, M., Kabiri, M., Rad, I., Parivar, K., Hoseinpoor, H. and Hanaee-Ahvaz, H. (2020) Combination of low intensity electromagnetic field with chondrogenic agent induces chondrogenesis in mesenchymal stem cells with minimal hypertrophic side effects. Electromagnetic Biology and Medicine 39, 154–165.10.1080/15368378.2020.1737809CrossRefGoogle ScholarPubMed
Hirshfield, A. N. (2013) Growth factors and the ovary. Springer Science & Business Media.Google Scholar
Homburg, R. and Crawford, G. (2014) The role of AMH in anovulation associated with PCOS: a hypothesis. Human Reproduction 29, 1117–1121.10.1093/humrep/deu076CrossRefGoogle ScholarPubMed
Hong, L., Yan, L., Xin, Z., Hao, J., Liu, W., Wang, S. and Yang, X. (2020) Protective effects of human umbilical cord mesenchymal stem cell-derived conditioned medium on ovarian damage. Journal of Molecular Cell Biology 12, 372–385.10.1093/jmcb/mjz105CrossRefGoogle ScholarPubMed
Hosseini, L., Shirazi, A., Naderi, M. M., Shams-Esfandabadi, N., Boroujeni, S. B., Sarvari, A. and Akhondi, M. M. (2017) Platelet-rich plasma promotes the development of isolated human primordial and primary follicles to the preantral stage. Reproductive biomedicine online 35, 343–350.10.1016/j.rbmo.2017.04.007CrossRefGoogle Scholar
Irving-Rodgers, H. F., Roger, J., Luck, M. R. and Rodgers, R. J. (2006) Extracellular matrix of the corpus luteum. In Seminars in reproductive medicine (Vol. 24, No. 04, pp. 242–250). Copyright© 2006 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA.Google Scholar
Jahan, S., Abid, A., Khalid, S., Afsar, T., Shaheen, G., Almajwal, A. and Razak, S. (2018) Therapeutic potentials of Quercetin in management of polycystic ovarian syndrome using Letrozole induced rat model: a histological and a biochemical study. Journal of ovarian research 11, 26–38.10.1186/s13048-018-0400-5CrossRefGoogle Scholar
Jafarzadeh, H., Nazarian, H., Ghaffari Novin, M., Shams Mofarahe, Z., Eini, F. and Piryaei, A. (2018) Improvement of oocyte in vitro maturation from mice with polycystic ovary syndrome by human mesenchymal stromal cell–conditioned media. Journal of cellular biochemistry 119, 10365–10375.10.1002/jcb.27380CrossRefGoogle ScholarPubMed
Kafali, H., Iriadam, M., Ozardalı, I. and Demir, N. (2004) Letrozole-induced polycystic ovaries in the rat: a new model for cystic ovarian disease. Archives of medical research 35, 103–108.10.1016/j.arcmed.2003.10.005CrossRefGoogle Scholar
Kalhori, Z., Azadbakht, M., Mehranjani, M. S. and Shariatzadeh, M. A. (2018) Improvement of the folliculogenesis by transplantation of bone marrow mesenchymal stromal cells in mice with induced polycystic ovary syndrome. Cytotherapy 20, 1445–1458.10.1016/j.jcyt.2018.09.005CrossRefGoogle ScholarPubMed
Khodaeifar, F., Fazljou, S. M. B., Khaki, A., Torbati, M., Madarek, E. O. S., Khaki, A. A. and Dalili, A. H. (2019) The effect of hydroalchoholic extract of cinnamon zeylanicum on oxidative damages and biochemical change in adult rats with polycystic ovary syndrome. Crescent Journal of Medical Biology 6, 1–12.Google Scholar
Liu, T., Huang, Y. and Lin, H. (2021) Estrogen disorders: Interpreting the abnormal regulation of aromatase in granulosa cells. International Journal of Molecular Medicine 47, 73–86.10.3892/ijmm.2021.4906CrossRefGoogle ScholarPubMed
Lloyd, A. C. (2013) The regulation of cell size. Cell 154, 1194–1205.10.1016/j.cell.2013.08.053CrossRefGoogle ScholarPubMed
Mariani, G., and Bellver, J. (2018) Management Options for Infertile Women with Polycystic Ovary Syndrome. US Endocrinology 14, 67–72.10.17925/USE.2018.14.2.67CrossRefGoogle Scholar
Mobeen, S. and Apostol, R. (2020) Ovarian cyst. In: StatPearls. StatPearls Publishing, Treasure Island.Google Scholar
Mohammadi, Z., Hosseinianvari, S., Ghazalian, N., Fani, M., Mahmudian, A. S., Brazvan, B. and Moghimian, M. (2022) The impact of chrysin on the folliculogenesis and ovarian apoptosis in ischemia-reperfusion injury in the rat model. International Journal of Fertility & Sterility 16, 299–306.Google ScholarPubMed
Mohammadi, S., Kayedpoor, P., Karimzadeh-Bardei, L. and Nabiuni, M. (2017) The effect of curcumin on TNF-α, IL-6 and CRP expression in a model of polycystic ovary syndrome as an inflammation state. Journal of reproduction & infertility 18, 352–364.Google Scholar
Myers, M., Britt, K. L., Wreford, N. G. M., Ebling, F. J. and Kerr, J. B. (2004) Methods for quantifying follicular numbers within the mouse ovary. Reproduction 127, 569–580.10.1530/rep.1.00095CrossRefGoogle ScholarPubMed
Noverina, R., Widowati, W., Ayuningtyas, W., Kurniawan, D., Afifah, E., Laksmitawati, D. R. and Wirakusumah, F. F. (2019) Growth factors profile in conditioned medium human adipose tissue-derived mesenchymal stem cells (CM-hATMSCs). Clinical Nutrition Experimental 24, 34–44.10.1016/j.yclnex.2019.01.002CrossRefGoogle Scholar
Noorafshan, A., Ahmadi, M., Mesbah, S. F. and Karbalay-Doust, S. (2013) Stereological study of the effects of letrozole and estradiol valerate treatment on the ovary of rats. Clinical and Experimental Reproductive Medicine 40, 115–124.10.5653/cerm.2013.40.3.115CrossRefGoogle ScholarPubMed
Noorafshan, A., Ahmadi, M., Mesbah, S. F. and Karbalay-Doust, S. (2013) Stereological study of the effects of letrozole and estradiol valerate treatment on the ovary of rats. Clinical and Experimental Reproductive Medicine 40, 115–123.10.5653/cerm.2013.40.3.115CrossRefGoogle ScholarPubMed
Ong, M., Cheng, J., Jin, X., Lao, W., Johnson, M., Tan, Y. and Qu, X. (2019) Paeoniflorin extract reverses dexamethasone-induced testosterone over-secretion through downregulation of cytochrome P450 17A1 expression in primary murine theca cells. Journal of Ethnopharmacology 229, 97–103.10.1016/j.jep.2018.09.006CrossRefGoogle ScholarPubMed
Ong, M., Peng, J., Jin, X. and Qu, X. (2017) Chinese herbal medicine for the optimal management of polycystic ovary syndrome. The American Journal of Chinese Medicine 45, 405–422.Google ScholarPubMed
Paradisi, G., Steinberg, H. O., Shepard, M. K., Hook, G. and Baron, A. D. (2003) Troglitazone therapy improves endothelial function to near normal levels in women with polycystic ovary syndrome. The Journal of Clinical Endocrinology & Metabolism 88, 576–580.10.1210/jc.2002-020386CrossRefGoogle ScholarPubMed
Patel, R. and Shah, G. (2018) High-fat diet exposure from pre-pubertal age induces polycystic ovary syndrome (PCOS) in rats. Reproduction 155, 139–149.10.1530/REP-17-0584CrossRefGoogle ScholarPubMed
Pandey, V., Singh, A., Singh, A., Krishna, A., Pandey, U. and Tripathi, Y. B. (2016) Role of oxidative stress and low-grade inflammation in letrozole-induced polycystic ovary syndrome in the rat. Reproductive biology 16, 70–77.10.1016/j.repbio.2015.12.005CrossRefGoogle ScholarPubMed
Pouryousefi-Koodehi, T., Shayegan, S., Hashemi, S., Arefnezhad, R., Roghani-Shahraki, H., Motedayyen, H. and Rezaei-Tazangi, F. (2022) Can mesenchymal stem cells derived from adipose tissue and their conditioned medium improve ovarian functions? A mini-review. Zygote 30, 589–592.10.1017/S0967199422000235CrossRefGoogle ScholarPubMed
Paris, V. R., Alexopoulos, S. J., Hu, Y., Shah, D. P., Aflatounian, A., Edwards, M. C. and Walters, K. A. (2021) Metabolic PCOS Features Are Ameliorated by Mitochondrial Uncoupler BAM15 in a PCOS Mouse Model. Journal of the Endocrine Society 5, A769–A775.10.1210/jendso/bvab048.1565CrossRefGoogle Scholar
Qian, Y., Han, Q., Chen, W., Song, J., Zhao, X., Ouyang, Y. and Fan, C. (2017) Platelet-rich plasma derived growth factors contribute to stem cell differentiation in musculoskeletal regeneration. Frontiers in chemistry 5, 89–69.10.3389/fchem.2017.00089CrossRefGoogle ScholarPubMed
Rafiee, Z., Rezaee-Tazangi, F., Zeidooni, L., Alidadi, H. and Khorsandi, L. (2021) Protective effects of selenium on Bisphenol A-induced oxidative stress in mouse testicular mitochondria and sperm motility. JBRA Assisted Reproduction 25, 459–463.Google ScholarPubMed
Rajan, R. K., M, S. S. K. and Balaji, B. (2017) Soy isoflavones exert beneficial effects on letrozole-induced rat polycystic ovary syndrome (PCOS) model through anti-androgenic mechanism. Pharmaceutical biology 55, 242–251.10.1080/13880209.2016.1258425CrossRefGoogle ScholarPubMed
Reddy, P. S., Begum, N., Mutha, S. and Bakshi, V. (2016) Beneficial effect of Curcumin in Letrozole induced polycystic ovary syndrome. Asian Pacific Journal of Reproduction 5, 116–122.10.1016/j.apjr.2016.01.006CrossRefGoogle Scholar
Rezaei-Tazangi, F., Samadi, A., Azandeh, S., Khoshnood, S. and Mahmoudvand, S. (2021). Secretome of adipose derived stem cells induced apoptosis in anaplastic thyroid carcinoma C-643 cells. Immunopathologia Persa 8, e20–e20.10.34172/ipp.2022.20CrossRefGoogle Scholar
Roshanaee, M. K., Abtahi-Eivary, S. H., Shokoohi, M., Fani, M., Mahmoudian, A. and Moghimian, M. (2022) Protective effect of minocycline on Bax and Bcl-2 gene expression, histological damages and oxidative stress induced by ovarian torsion in adult rats. International Journal of Fertility & Sterility 16, 30–42.Google Scholar
Salmabadi, Z., Kouchesfahani, H. M., Parivar, K. and Karimzadeh, L. (2017) Effect of grape seed extract on lipid profile and expression of interleukin-6 in polycystic ovarian syndrome wistar rat model. International journal of fertility & sterility 11, 176–188.Google ScholarPubMed
Soltani, M., Moghimian, M., Abtahi-Evari, S. H., Esmaeili, S. A., Mahdipour, R. and Shokoohi, M. (2023) The effects of clove oil on the biochemical and histological parameters, and autophagy markers in polycystic ovary syndrome-model rats. International journal of fertility & sterility 17, 187–191.Google ScholarPubMed
Shabbir, S., Khurram, E., Moorthi, V. S., Eissa, Y. T. H., Kamal, M. A. and Butler, A. E. (2023) The interplay between androgens and the immune response in polycystic ovary syndrome. Journal of Translational Medicine 21, 259–266.10.1186/s12967-023-04116-4CrossRefGoogle ScholarPubMed
Tohma, Y. A., Onalan, G., Tepeoglu, M., Bayraktar, N., Colak, E., Ozcimen, E. E. and Zeyneloglu, H. B. (2019) Phosphodiesterase 4 inhibitor plus metformin is superior to metformin alone for the treatment of polycystic ovary syndrome: A rat model study. Experimental and therapeutic medicine 17, 4013–4022.Google ScholarPubMed
Ullah, A., Jahan, S., Razak, S., Pirzada, M., Ullah, H., Almajwal, A. and Afsar, T. (2017) Protective effects of GABA against metabolic and reproductive disturbances in letrozole induced polycystic ovarian syndrome in rats. Journal of ovarian research 10, 62–75.10.1186/s13048-017-0359-7CrossRefGoogle ScholarPubMed
Xiang, Y., Wang, H., Ding, H., Xu, T., Liu, X., Huang, Z. and Ge, H. (2023) Hyperandrogenism drives ovarian inflammation and pyroptosis: A possible pathogenesis of PCOS follicular dysplasia. International immunopharmacology 125, 111–122.10.1016/j.intimp.2023.111141CrossRefGoogle ScholarPubMed
Yamaguchi, S., Shibata, R., Yamamoto, N., Nishikawa, M., Hibi, H., Tanigawa, T. and Yamamoto, A. (2015) Dental pulp-derived stem cell conditioned medium reduces cardiac injury following ischemia-reperfusion. Scientific reports 5, 162–171.10.1038/srep16295CrossRefGoogle ScholarPubMed
Yan, Z., Guo, F., Yuan, Q., Shao, Y., Zhang, Y., Wang, H. and Du, X. (2019) Endometrial mesenchymal stem cells isolated from menstrual blood repaired epirubicin-induced damage to human ovarian granulosa cells by inhibiting the expression of Gadd45b in cell cycle pathway. Stem Cell Research & Therapy 10, 4–21.10.1186/s13287-018-1101-0CrossRefGoogle ScholarPubMed
Yang, C., Lei, D., Ouyang, W., Ren, J., Li, H., Hu, J. and Huang, S. (2014) Conditioned media from human adipose tissue-derived mesenchymal stem cells and umbilical cord-derived mesenchymal stem cells efficiently induced the apoptosis and differentiation in human glioma cell lines in vitro. BioMed research international 2014, 109–122.10.1155/2014/109389CrossRefGoogle Scholar
Ye, W., Xie, T., Song, Y. and Zhou, L. (2021) The role of androgen and its related signals in PCOS. Journal of cellular and molecular medicine 25, 1825–1837.10.1111/jcmm.16205CrossRefGoogle ScholarPubMed
Zand, E., Fathi, R., Nasrabadi, M. H., Atrabi, M. J., Spears, N. and Akbarinejad, V. (2018) Maturational gene upregulation and mitochondrial activity enhancement in mouse in vitro matured oocytes and using granulosa cell conditioned medium. Zygote 26, 366–371.10.1017/S0967199418000333CrossRefGoogle ScholarPubMed
Zhu, T., Cui, J., and Goodarzi, M. O. (2021) Polycystic ovary syndrome and risk of type 2 diabetes, coronary heart disease, and stroke. Diabetes 70, 627–637.10.2337/db20-0800CrossRefGoogle ScholarPubMed